ADiTx Inc (ADTX): Watching. $28 after RS. Unbelievable d...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	83
Posts	8443
Boards Moderated	0
Alias Born	08/31/2007

kzivann

Re: None

Friday, 09/16/2022 3:05:52 PM

Friday, September 16, 2022 3:05:52 PM

Watching. $28 after RS. Unbelievable drop.

ADTX

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ADTX News

Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/14/2024 08:01:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:35:45 PM
Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 06/07/2024 09:12:12 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/29/2024 08:33:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 10:08:41 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:24:20 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:15:45 PM
Evofem Biosciences Announces Financial Results for the First Quarter of 2024 • PR Newswire (US) • 05/15/2024 10:50:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:15:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:15:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:15:44 PM
CORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules • Business Wire • 05/03/2024 06:14:00 PM
Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules • Business Wire • 05/03/2024 01:00:00 PM
Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD) • Business Wire • 04/02/2024 12:30:00 PM
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 • PR Newswire (US) • 03/27/2024 12:36:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:51:37 PM
For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy • PR Newswire (US) • 03/07/2024 12:54:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/04/2024 10:27:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 10:24:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:01:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:01:59 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/22/2024 10:21:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:30:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:30:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:30:52 PM

More ADTX News

InvestorsHub NewsWire

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover